AMGEN reports breach to SEC

Amgen reported a material cybersecurity incident in July 2026 involving unauthorized access to data stored in third‑party cloud environments; some proprietary data and patient protected health information were exfiltrated. The company activated its incident response plan, engaged forensic experts, implemented containment, and is investigating while assessing regulatory and notification obligations; no impact to products, manufacturing, or financial reporting has been identified so far.